Metropolitan Life Insurance Company (MetLife)’s Apogee Therapeutics APGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,185	Closed	-$145K	–	154
2024 Q1	$145K	Buy	2,185 +1,011	+86%	+$67.2K	0.01%	858
2023 Q4	$32.8K	Hold	1,174	–	–	﹤0.01%	1661
2023 Q3	$25K	Buy	+1,174	New	+$25K	﹤0.01%	1784